The MRC International Nutrition Group (MRC ING) will become fully integrated into the MRC Unit, The Gambia with effect from 1 April 2014. The move follows ING’s successful bid for renewed funding (2014-2019). (more…)
Established in The Gambia in 1947, the MRC is the UK's single largest investment in medical research in a developing country. The Unit's research focuses on infectious diseases of immediate concern to The Gambia and the continent of Africa, with the aim of reducing the burden of illness and death in the country and the developing world as a whole. read more
The scientific evidence supporting the value of vaccination is overwhelming: In terms of reducing the burdenLearn more
In recent times, several diseases have reduced very markedly in incidence in The GambiaLearn more
In common with most developing countries, The Gambia has high infant and child mortality ratesLearn more
The MRC research programme in The Gambia is in the process of reorganization into three new, interlinking, scientific themes: Child Survival, Disease Eradication and Vaccinology.
Emeritus Scientist Professor Hilton Whittle has been studying some of the leading causes of illness and death in the developing world for almost forty years. Hilton, a pioneer of the Gambia Hepatitis Intervention Scheme (GHIS), gives a potted history of one of the longest running longitudinal studies of an infectious disease in the Tropics.
- Detecting Foci of Malaria Transmission with School Surveys: A Pilot Study in the Gambia.
- The First Phylogeographic Population Structure and Analysis of Transmission Dynamics of M. africanum West African 1- Combining Molecular Data from Benin, Nigeria and Sierra Leone.
- Haematological and biochemical reference values of Gambian infants.
PO Box 273, Banjul
T: +220 4495442/6 or 4494072/9
F: Administration +220 4495919